Abstract
Hypoxic mesenchymal stem cells (MSCS)-induced interleukin (IL)-10 alleviate systemic lupus erythematosus (SLE) infl ammation through inhibiting interferon (IFN)-gamma production
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have